Apolipoprotein E in Alzheimer's disease and other neurological disorders
Top Cited Papers
- 31 March 2011
- journal article
- review article
- Published by Elsevier
- Vol. 10 (3) , 241-252
- https://doi.org/10.1016/s1474-4422(10)70325-2
Abstract
No abstract availableKeywords
This publication has 182 references indexed in Scilit:
- Variants at APOE influence risk of deep and lobar intracerebral hemorrhageAnnals of Neurology, 2010
- Biomarkers in translational research of Alzheimer’s DiseaseNeuropharmacology, 2010
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascadePublished by Elsevier ,2010
- APOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal agingAnnals of Neurology, 2010
- Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal agingNeuroImage, 2010
- Multimodal techniques for diagnosis and prognosis of Alzheimer's diseaseNature, 2009
- The Role of Apolipoprotein E in Alzheimer's DiseaseNeuron, 2009
- Resting-state BOLD networks versus task-associated functional MRI for distinguishing Alzheimer's disease risk groupsNeuroImage, 2009
- Significant effect of APOE epsilon 4 genotype on the risk of dementia in Alzheimer's disease and mortality in persons with Down SyndromeInternational Journal of Geriatric Psychiatry, 2008
- ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brainPublished by Elsevier ,2007